Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 4
2021 5
2022 5
2023 1
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study.
Fumery M, Caron B, Hébuterne X, Altwegg R, Roblin X, Stefanescu C, Meyer A, Nachury M, Laharie D, Le Berre C, Guillo L, Biron A, Caillo L, Buisson A, Nancey S, Uzzan M, Vuitton L, Gilletta C, Geyl S, Blain A, Kirchgesner J, Ah-Soune P, Duveau N, Vidon M, Abitbol V, Paupard T, Tran-Minh ML, Defrance A, Peyrin-Biroulet L. Fumery M, et al. Among authors: vidon m. Clin Gastroenterol Hepatol. 2024 Dec;22(12):2451-2458.e1. doi: 10.1016/j.cgh.2024.04.016. Epub 2024 May 9. Clin Gastroenterol Hepatol. 2024. PMID: 38729389
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Osty M, Altwegg R, Serrero M, Benezech A, Lecomte A, Cadiot G, Vuitton L, Wampach A, Nancey S, Buisson A, le Berre C, Rouillon C, Gilletta C, Goutorbe F, Fumery M, Hammoudi N, Caillo L, Vidon M, Arab N, Sickersen G, Cavicchi M, Vieujean S, Charkaoui M, Richard N, Wils P, Caron B, Amiot A, Nuzzo A, Laharie D, Kirchgesner J, Uzzan M; GETAID‐J2J group. Osty M, et al. Among authors: vidon m. Aliment Pharmacol Ther. 2025 Aug;62(4):430-439. doi: 10.1111/apt.70199. Epub 2025 May 22. Aliment Pharmacol Ther. 2025. PMID: 40400411 Free PMC article.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study.
Le Cosquer G, Kirchgesner J, Gilletta De Saint Joseph C, Seksik P, Amiot A, Laharie D, Nachury M, Rouillon C, Abitbol V, Nuzzo A, Nancey S, Fumery M, Biron A, Richard N, Altwegg R, Moussata D, Caron B, Vidon M, Reenaers C, Uzzan M, Reimund JM, Serrero M, Simon M, Benezech A, Goutorbe F, Pelletier AL, Caillo L, Vaysse C, Poullenot F; GETAID. Le Cosquer G, et al. Among authors: vidon m. Clin Gastroenterol Hepatol. 2025 Sep;23(10):1824-1833.e3. doi: 10.1016/j.cgh.2024.09.034. Epub 2024 Nov 5. Clin Gastroenterol Hepatol. 2025. PMID: 39505240 Free article.
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.
Richard N, Amiot A, Seksik P, Altwegg R, Laharie D, Vuitton L, Nachury M, Bouguen G, Nancey S, Gilletta C, Rouilon C, Coffin B, Allez M, Buisson A, Le Berre C, Uzzan M, Caillo L, Pelletier AL, Peyrin-Biroulet L, Fumery M; GETAID. Richard N, et al. Aliment Pharmacol Ther. 2025 May;61(10):1662-1670. doi: 10.1111/apt.70073. Epub 2025 Mar 4. Aliment Pharmacol Ther. 2025. PMID: 40038887 Free PMC article.
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus.
Guillo L, Delanaye P, Flamant M, Figueres L, Karam S, Lemoine S, Benezech A, Pelletier AL, Amiot A, Caron B, Stefanescu C, Boschetti G, Bouguen G, Rahier JF, Gornet JM, Hugot JP, Bonnet J, Vuitton L, Nachury M, Vidon M, Uzzan M, Serrero M, Dib N, Seksik P, Hebuterne X, Bertocchio JP, Mariat C, Peyrin-Biroulet L. Guillo L, et al. Among authors: vidon m. Dig Liver Dis. 2022 Mar;54(3):309-315. doi: 10.1016/j.dld.2021.11.008. Epub 2021 Dec 2. Dig Liver Dis. 2022. PMID: 34866011 Free article. Review.
Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption.
Amoura A, Frapard T, Treton X, Surgers L, Beaugerie L, Lafaurie M, Gornet JM, Lepeule R, Amiot A, Canouï E, Abitbol V, Froissart A, Vidon M, Nguyen Y, Lefort A, Zarrouk V. Amoura A, et al. Among authors: vidon m. Open Forum Infect Dis. 2024 Jun 17;11(7):ofae327. doi: 10.1093/ofid/ofae327. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 38957691 Free PMC article.
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Wils P, Altwegg R, Buisson A, Vuitton L, Nancey S, Richard N, Fumery M, Bouguen G, Guillo L, Caron B, Duveau N, Stefanescu C, Pelletier AL, Reenaers C, Gilletta C, Uzzan M, Arab N, Laharie D, Vidon M, Amiot A, Le Berre C, Kirchgesner J, Dewit O, Simon M, Goutorbe F, Vicaut E, Peyrin-Biroulet L; Groupe d‘Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Wils P, et al. Among authors: vidon m. J Crohns Colitis. 2025 Sep 28;19(9):jjaf166. doi: 10.1093/ecco-jcc/jjaf166. J Crohns Colitis. 2025. PMID: 40929061
Acute dysphagia in a patient with Crohn disease.
Vidon M, Perrod G, Rahmi G, Cellier C. Vidon M, et al. Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):349-350. doi: 10.1016/j.clinre.2017.01.002. Epub 2017 Feb 23. Clin Res Hepatol Gastroenterol. 2017. PMID: 28237827 No abstract available.
18 results